Stanford inventors have developed a method to create spatially micropatterned vascularized structures that enable in vitro representation of human and animal biology in models such as cells, tissues, organs, and organoids.
Adeno-associated virus (AAV) vectored products are currently leading candidates for gene therapy applications with multiple approved products and many more in clinical trials.
Stanford researchers have discovered a new class of metallic glass alloys with superior properties such as low cost, high wear resistance, and electric conductivity comparable to graphite.
Stanford inventors have developed a molecular design concept that allows for the development of stretchable electronics with desirable elasticity, solvent resistance, and photopatternability using covalently-embedded in-situ rubber matrix formation (iRUM).
Stanford researchers developed a programmable tuning circuit for dynamic, all-electronic tuning of the resonance frequency, sensitivity, and bandwidth of ultrasound transducers.
Stanford researchers developed a device that emits electromagnetic radiation that oscillates between at least first and second distinct polarization states.
Antimicrobial peptoids are promising leads for novel antibiotics; however, their activity is often compromised under physiological conditions. Inventors at Stanford enhanced the efficacy of antimicrobial peptoids by using thiourea and thiourea derivatives.
The blood-brain barrier is a huge challenge when it comes to the delivery of therapeutic proteins to treat genetic diseases, injury, and neurodegenerative diseases.
Stanford researchers developed a novel flexible smart bandage capable of delivering precise electrical stimulation as part of an early response to wound infections.
Researchers at Stanford have developed a gene expression-based method for determining a virally infected patient's risk of developing severe symptoms, irrespective of the virus.
Stanford inventors have found that Stanniocalcin 2 (STC2) treatment following stoke leads to improved functional recovery and a pharmaceutical composition containing STC2 as an active ingredient can be used to facilitate post stroke recovery.
Stanford researchers in the Woo Lab have developed a novel device that allows for direct visual assessment of the aortic valve apparatus under physiologic pressure in aortic valve procedures.
Stanford inventors in the Katrin Svensson laboratory have identified the protein Isthmin-1 (ISM1) as a treatment for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).